The rise and fall of Elizabeth Holmes, the former CEO of the now-defunct health technology company Theranos, is a case study of how greed for wealth has, in many cases, been overtaken by greed for influence.
Holmes claimed Theranos had technology capable of doing hundreds of different tests utilizing only a few drops of blood as opposed to drawing with a needle. Those claims turned out to be false and Holmes is under federal indictment for wire fraud for bilking investors, doctors, and patients.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.
